Amy Doneen, DNP, ARNP

Medical Director, Heart Attack & Stroke Prevention Center
Adjunct Professor Texas Tech Health Sciences, School of Nursing

a: 507 S. Washington #170 | Spokane, WA 99204
p: 509.747.8000
f: 509.747.8051
w: |

Dr. Amy L. Doneen, DNP
Medical Director of the Heart Attack & Stroke Prevention Center

Heart Attack & Stroke Prevention Center
507 South Washington Street, No. 170
Spokane, WA 99204

Office: (509) 747-8000
Fax: (509)747-8051
Cell: (509) 953-3377


Clinical Associate Professor Washington State University College of Medicine, Spokane, Washington

Assistant Professor University of Kentucky College of Dentistry, Lexington, Kentucky

Adjunct Professor Texas Tech Health Science School of Nursing, Lubbock, Texas.


Gonzaga University, January 2013 to November 2014
Degree in progress: Doctor of Nursing Practice (DNP)

  • Graduation: December 2014
  • Major area of focus: Closing the gap: Using current literature to improve evidence-based CVD risk assessment in primary care.

Gonzaga University, January 1999 to May 2003
Degrees completed: Advanced Registered Nurse Practitioner (ARNP);
Master of Science in Nursing (MSN);
Bachelor of Science in Nursing (BSN)

  • Summa cum laude graduate
  • Thesis published April 2003 by University Press: The Relationship between Electron Beam Computed Tomography Calcium Scores and established Clinical and Serologic Risk Factors for Coronary Artery Disease

Eastern Washington University, September 1990 to June 1991
General studies, ADN-RN, Spokane Community College 1992-1994

Western Washington University, September 1988 to June 1990
General studies


Owner and Medical Director of the Heart Attack & Stroke Prevention Center,
Spokane, Washington (2005 to present).

Co-owner of the Bale/Doneen Method for the Prevention of Heart Attacks, Ischemic Strokes and Diabetes (2004 to present).

Cofounder of the Heart Attack Prevention Clinic, in partnership with Dr. Bradley Bale, Spokane, Washington (1999 to 2005).

Adjunct Professor at Texas Tech Health Sciences School of Nursing, Lubbock, Texas (2008 to present).

Consultant to MyGenetx, Tennessee (2016 to present)

Consultant to Cleveland Heart Labs, Ohio (2010 to present).

Consultant to Berkeley Heart Labs, California (2009 to 2012).


Bale, B., Doneen, A., Collier-Cool, L. (2014). Beat the Heart Attack Gene: The Revolutionary Plan to Prevent Heart Disease, Stroke, and Diabetes. Nashville, TN: Wiley.


Bale, B.F., Doneen A.D., Vigerust, D.J. (2016) High-risk periodontal pathognes contribute to the pathogenesis of atherosclerosis.  Postgrad Med J. November 29, 2016 as 10.1136.  Open Access

Cheng, H.G., B.S. Patel, S.S. Martin, M. Blaha, A. Doneen, B.Bale and S.R. Jones (2016). Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community based prevention clinic.” Archives of Medical Science 12(4):728-735.

Doneen, A.L., Dupler, A., & Crogan, A. Why the RDH is a critical member of the health-care team. Registered Dental Hygiene Program. February 2014

Doneen, A.L. The direct program: A disease/inflammatory vs risk factor evaluation cardiovascular testing program.  The International Journal of Nursing & Clinical Practices. December 24, 2014.

Doneen, A.L., Dupler, A., & Crogan, N. Cardiovascular wellness and optimal oral health: A symbiotic relationship. Heart Health. November 26, 2014.

Feng, D., Esperat, C., Doneen, A., Bale, B., Song, Hauxin, Green, A. 8 Year Outcomes of a Program for early prevention of cardiovascular events: A growth-curve analysis.  Journal of Cardiovascular Nursing. 2014. 00. No.0.

Bale, B., Doneen. A. A guarantee of arterial wellness; new era of cardiovascular medicine. Clinical & Experimental Cardiology. 2014.

Doneen, A. L., & Bale, B.F. (2013). Carotid intima-media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutic decisions. Postgraduate Medicine125(2),108–23. 2013 doi:10.3810/pgm.2013.03.2645.

Doneen, A. L., & Bale, B. F. (2013). Autophagy, senescence, and arterial inflammation: relationship to arterial health and longevity. Alternative Therapies in Health and Medicine19(4), 8–10.

Mason, C. M., & Doneen, A. L. (2012). Niacin—A critical component to the management of atherosclerosis: contemporary management of dyslipidemia to prevent, reduce, or reverse atherosclerotic cardiovascular disease. Journal of Cardiovascular Nursing27(4), 303–316.  doi:10.1097/JCN.0b013e31821bf93f

Nabors, T., Bale, B., & Doneen, A. (2012). Inculpatory evidence: periodontal disease assessment and treatment is an essential element in cardiovascular wellness programs. Dental Economics102(9), 99.

Jones, P. H., Bale, B., & Doneen, A. (2011). Clinician perspective on the benefits of niacin therapy for the treatment of dyslipidemia and strategies to improve long-term adherence to therapy. The Medical Roundtable—Cardiovascular Edition2(4): 249–55.

Taylor, A. J., Olendorf, M. W., DeMichele, M., Doneen, A. L., Faulkner, D. A., Sutton-Tyrell, K. (2011). Appropriate use criteria for carotid intima media thickness testing,

Society of Atherosclerosis Imaging and Prevention, developed in collaboration with the International Atherosclerosis Society. Atherosclerosis214(1): 43–46. doi:10.1016/j.atherosclerosis.2010.10.045

Bale, B., Doneen, A., & Wegner, M. (2009). The identification of occult cardiovascular disease through the use of a novel biomarker: a case report. Journal of Clinical Lipidology3(5), 351–54. doi:10.1016/j.jacl.2009.08.004 

Bale, B. F., Doneen, A.L., Drueding, R., & Charland, S.L. (2006). Aggressive risk factor modification in patients with sub-clinical atherosclerosis reduces plaque burden and regresses carotid artery wall thickness. Atherosclerosis7(3), 161.

Doneen, A. L., Bale, B. F., Charland, S. L., & Smith, T.F. (2006). Carotid intima-media thickness testing identifies at risk patients missed by Framingham 10-year risk scoring. Atherosclerosis, 7(3), 324.


  • 2016 – Keynote lecture at the Seattle Study Club annual meeting Hawaii, Seattle Study club several study club meetings around the country. Bale/Doneen Preceptorship programs, NextLevel Practice keynote, Pacific Dental Services specialized preceptorship. WAPA
  • 2016 – Keynote lectures with Seattle Study Club, Washington State Dental Association, Cleveland HeartLab, MDVIP, American Heart Association
  • BaleDoneen Preceptorship Program. 17.5 CME hours – American Academy of Family Physicians. Offered twice per year at varied locations.
  • On-line Genetic CME courses – Atrial Fibrillation and Women’s Heart Health.
  • 2015 – numerous keynote lectures – MDVIP, Cleveland Heart Lab, Bale/Doneen Preceptorships, Bale/Doneen reunion. Washington Association of Physician Assistant annual meeting, Keynote Spokane Nurse Practitioner Association
  • Keynote address: Say Ahhhh – the Oral Systemic Connection April 2014. Tri Cities Washington“
  • “Arteriology: Where disease and inflammation collide. Recognizing the Oral/Systemic Connection,” A. Doneen. Keynote speaker, American Academy for Oral Systemic Health Science Meeting, St. Louis Missouri: September 2014.
  • “Arteriology: Where disease and inflammation collide. Recognizing the Oral/Systemic Connection,” B. Bale & A. Doneen. Featured speaker, American Academy for Oral Systemic Health Science Meeting, Las Vegas, NV: September 2013.
  • “Brain Health as it Relates to Cardiovascular Wellness: Minorities Carry Higher Risk and Lower Awareness,” A. Doneen & B. Bale. Seminar presentation, American Osteopathic Association Annual Osteopathic Medical Conference and Exposition, Las Vegas, NV: September 2013.
  • “Independent Effects of Risk Factors and Treatment on Carotid Intima-Media Thickness Progression in a Community Practice American Heart Association,” B. Patel, M. Blaha, A. Doneen, B. Bale, & S. Jones. American Heart Association Scientific Sessions, Los Angeles, CA: November 2012.
  • “Carotid Intima-Media Thickness: Refining Cardiovascular Disease Risk Prediction and Evaluating Effects of Lipid Therapies,” A. L. Doneen & C. M. Mason. Poster presentation, Preventive Cardiovascular Nurses Association Annual Symposium, Lake Buena Vista, Florida: March 2011.
  • “113 Patients with Atherosclerosis Missed by Framingham 10-year Risk Scoring,” A. Doneen, B. Bale, & D. Feng. International Symposium on Atherosclerosis, Boston MA: June 2009.
  • “Carotid Intima-media thickness augments Framingham scoring in assessing CV risk in metabolic syndrome patients,” A. L. Doneen, B. F. Bale, & S. L. Charland. Congress of the European Atherosclerosis Society, Helsinki, Finland: June 2007.
  • “Effect of aggressive CV risk factor management on lipoproteins and carotid intima-media thickness in patients with metabolic patients,” B. F. Bale, A. L. Doneen, & S. L. Charland, Congress of the European Atherosclerosis Society, Helsinki, Finland: June 2007.
  • “The Effectiveness of Multiple Interventions on Carotid Artery Atherosclerosis in a Clinical Setting,” B. F. Bale, A. L. Doneen, & T. F. Smith, poster presentation, Conference on Arteriosclerosis, Thrombosis, and Vascular Biology, Washington, DC, April 2005.
  • Cleveland Heart Lab Annual Symposium: 2011, 2012, 2013, 2014
  • National DO Meeting Annual conference: 2012 and 2013
  • North Carolina National Family Practice Meeting: 2012.
  • Reno Medical School Annual Conference: 2010, 2012 and 2013
  • Clevelend Heart Lab 5 hour CME program, multiple U.S. cities: 2012, 2013
  • Berkeley Heart Lab National Speakers series, multiple U.S. cities: 2010 and 2011.
  • WAPA conference: 2010 and 2012.
  • Keynote speaker, American Academy of Oral Systemic Health: June 2011
  • Society for Atherosclerosis Imaging Prevention, Bethesda, MD: April 2011.
  • Keynote speaker, American Academy of Private Physicians annual symposium: 2011.
  • Presenter, European Atherosclerotic Society Meeting, Helsinki, Finland: 2008.
  • Keynote speaker, Women’s Heart Symposium, Beverly Hills, CA; Cheyenne, Wyoming; Lubbock, Texas: 2009 and 2010.
  • Podium presenter, International Society of Atherosclerosis, Boston, MA: June 2009.
  • Keynote speaker, National DO meeting. Las Vegas, NV: 2008
  • Keynote speaker, West Texas Cardiac Symposium: 2007.
  • Keynote speaker, West Texas Women’s Health Symposium: 2007.
  • Speaker, Cheyenne Wyoming’s American Heart Disease luncheon for women.
  • Keynote speaker at the California State NP meeting in San Diego, CA.
  • Keynote speaker at the Washington State Association of CV Nurses.
  • Keynote speaker, First Annual Cardiovascular Symposium at St. James Heart & Vascular Institute, Tinley Park, IL.
  • Poster presentation, Annual Atherosclerosis, Thrombosis, and Vascular Biology Conference with the AHA. Washington, DC: April 2004.
  • Keynote speaker, Wyoming State NP/PA Association.
  • Speaker, “Know Your Risk,” Sacred Heart Women’s Show, 2006.
  • Speaker, “Metabolic Syndrome,” Washington State Academy of Physician Assistants, Spokane, WA. October 2007.
  • Podium presentation, International Society of Atherosclerosis, Rome, Italy. June 2006.
  • Chairperson: Neva L. Crogan, PhD, GCNS-BC, GNP-BC, FNGNA, FAAN
  • Committee persons: Alice E. Dupler, JD, APRN-BC, ANP-BC, GCNS-BC
  • Agency affiliation: Gonzaga University
  • Completion date December 2014
  • Description: Identifying the barriers associated with the implementation of evidence-based nursing practice: using a CME approved cardiovascular disease program for the assessment of vascular health.


  • Lloyd Rudy Leadership Award AAOSH 2015
  • Society of Atherosclerosis Imaging Prevention committee chair 2012
  • Society of Atherosclerosis Imaging Prevention Scientific Sessions: Appropriate use committee, April 2011
  • Oral presentation at the International Atherosclerosis Society meeting, Boston, MA, June 2009
  • Committee member (12-person international committee) for the definition and clinical utility of cIMT with the SAIP society 2009-2010
  • Bale/Doneen Preceptorship course AAFP accreditation for category 1 CME hours.
  • International advisory board on the clinical utility of CIMT—roundtable meeting in Washington, DC, September 2008—12-member panel of U.S. and Italian medical providers.
  • Cochair of National 5.5-hour National CME program addressing residual risk in CV disease. Development and delivery of program to 20 major U.S. cities in 2008 and 2009.
  • Chair of the Pacific Northwest Preventative Cardiovascular Nurses Association 2007-2010
  • Principle Instructor of the Bale/Doneen Preceptorship 40-hour CME program 2006-2010
  • Presentation at the European Atherosclerosis Society 76th annual conference in Helsinki, Finland on June 10, 2007.
  • Member of 4 person National committee for the development and allocation of a National CME grand round presentation on metabolic syndrome – Grundy, Sacks, Doneen, Kountz – 2007.
  • International board member of DeCODE genetics, investigating the role of genetics in the clinical arena.
  • Presentation at the Sixth Annual Atherosclerosis and Vascular Biology Conference 2005
  • Podium speaking presentation at the International Symposium of Atherosclerosis, Rome, Italy 2006
  • Summa cum laude graduate of Gonzaga University


  • Member of the American Heart Association.
  • Member of the American Stroke Association.
  • Member of the National Lipid Association
  • Member of the American Diabetic Association.
  • Founding Member of the American Academy of Oral Systemic Health
  • Member of the Coalition for the Diagnosis and Treatment of Peripheral Arterial Disease
  • Member of the Society for Atherosclerosis, Imaging, Prevention
  • Member of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
  • Member of the American Academy of Private Physicians
  • Chair of the Pacific Northwest chapter of the Preventative Cardiovascular Nurses Association
  • Cofounder of the Heart Attack Prevention Clinic and The Bale/Doneen Method of CHD Prevention, in partnership with Dr. Bradley Bale, MD.
  • Active member of Sigma Theta Tau International; a nursing honor society focused on nursing research and nursing education.
  • Nurse Practitioner Group of Spokane; a monthly continuing educational seminar forum.
  • Member of steering committee for “Healthy U” at Deaconess Medical Center.

Amy L Doneen, DNP is an international leader in preventing heart attacks, stroke, and diabetes, co-founder of the BaleDoneen Method and a principal instructor in the BaleDoneen Method, training other medical, dental and healthcare providers across the country. She is also the owner and Medical Director of the sought-after private clinical practice in Spokane, Washington, The Heart Attack & Stroke Prevention Center, which serves patients from all over the world. Dr. Doneen is an Adjunct Professor at Texas Tech Health Sciences School of Nursing, Clinical Associate Professor at Washington State University College of Medicine, Assistant Professor at University of Kentucky College of Dentistry. and chair of the Pacific Northwest Preventative Cardiovascular Nurses Association.She is co-author of the bestselling book, Beat The Heart Attack Gene.

Since 2002, she has given well over 1000 lectures, presentations and key-note speeches to medical, dental, nursing and healthcare groups in the US and abroad, including the American Heart Association, Cleveland Heart Lab, MD-VIP, International Atherosclerotic Society, and the European Atherosclerosis Society. Dr. Doneen has presented data in the United States, Finland, Spain, and Italy. Her media interviews include Fox news TV and radio, ABC TV, The Wall Street Journal, Huffington Post and ESPN, which reported on how Dr. Doneen screened coaches, scouts and former players from Seattle Seahawks football team for cardiovascular disease (CVD), using a state-of-the-art ultrasound test.

Dr. Doneen is cofounder of the Bale/Doneen Method international preceptorship program, an accredited continuing medical education (CME) course teaching health care providers advanced techniques to detect—and reverse—CVD before the patient suffers a heart attack or stroke. Hundreds of MDs, ARNP’s, dentists and healthcare specialists have completed the training, some of whom subsequently opened their own prevention clinics, hailing the course “an incredible resource…the future of medicine,” “the best, by far, educational program I have ever attended,” and “the education of a lifetime…the only totally comprehensive program in the world for the prevention of this disease.” For the last 16 years, Dr. Doneen has been recognized as an international leader in the prevention of heart attacks, strokes and type 2 diabetes. She continues to pave the way for other nurse practitioners and lectures to all audiences, including cardiology, dentistry, internal medicine, family practice, nursing and functional medicine. She is convinced that cardiovascular prevention should be integrated into all medical, nursing and dental practices. Convinced that the standard of care leaves people at risk for the deadly morbidity and mortality associated with cardiovascular events, she continues to practice the science and art of CV prevention while publishing her ambulatory research and lecturing to groups across the country.

It is her belief that the BaleDoneen Method can eradicate cardiovascular disease events as the number cause of death by the year 2020. Doneen has presented her research to the American Heart Association, International Atherosclerosis Society, European Atherosclerosis Society and the Atherosclerosis, Thrombosis and Vascular Biology Society. She has published her research in many medical, nursing and dental journals including the American Heart Association’s Circulation, Atherosclerosis, the official journal of the European Atherosclerosis Society, Post Graduate Medicine, Journal of National Medical Association, Journal of Clinical Lipidology, Physician’s Weekly, and Journal of Clinical Lipidology, ADVANCE for Administrators of the Laboratory and ADVANCE for Healthy Aging. Doneen has also served as a consultant to deCODE Genetics and Cleveland HeartLab. Dr. Doneen is an adjunct professor and the Texas Tech Health Sciences, School of Nursing in Lubbock Texas. She received her bachelors, masters and doctoral degree from Gonzaga University in Spokane WA. Dr. Doneen is a member of American Heart Association, American Stroke Association, American Diabetes Association, American Lipid Association, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Society of Atherosclerosis Imaging and Prevention and other medical and nursing societies.